Le Lézard
Classified in: Health
Subjects: NPT, AVO

NJHA Advocates for Opioid Crisis Solutions in D.C.


PRINCETON, N.J., March 14, 2018 /PRNewswire-USNewswire/ -- Members and staff of the New Jersey Hospital Association were in Washington, D.C., today to advocate for a multi-pronged solution to the opioid epidemic facing the country.

A priority among the legislative tools available is the Alternatives to Opioids (ALTO) in the Emergency Department Act, based on a model pioneered in New Jersey to promote alternative pain management protocols to limit the use of opioids in hospital emergency departments. The ALTO program was developed at St. Joseph's University Medical Center, in Paterson, and has shown a total reduction of 82 percent of opioid use in the emergency department in two years.

The legislation would provide grant funding to build ALTO demonstration programs in other areas. Following completion of the program the Secretary of Health and Human Services will submit a report to Congress on the results and issue recommendations for broader implementation.

U.S. Sens. Cory A. Booker (D-N.J.), Shelley Moore Capito (R-W.Va.), Michael F. Bennet (D-Colo.) and Cory Gardner (R-Colo.) along with U.S. Representatives Bill Pascrell Jr. (D-N.J.), David B. McKinley (R-W. Va.), Diana DeGette (D-Colo.) and Scott R. Tipton (R-Colo.) introduced the bill to help boost hospitals' resources in the fight against opioid addiction.

The NJHA delegation also advocated for these additional solutions:

"We are grateful that our elected representatives are working with us to curb the opioid crisis and ensure access to treatment and care for those who are suffering," said Sean Hopkins, senior vice president of federal relations and health economics for NJHA. "No one program or organization will solve this issue; we must all work together for the health of our state and nation."

In addition to speaking with the New Jersey delegation on the opioid epidemic, the group addressed federal concerns including cuts to the 340B drug pricing program, which helps hospitals provide care for low-income patients; cuts to the Public Service Loan Forgiveness program, which reduces or eliminates student debt for providers who practice in underserved communities; the Graduate Medical Education program; and support for legislation that would reduce paperwork redundancy and increase access to home healthcare.

Representatives from Atlantic Health System, Capital Health, Christian Health Care Center, Cooper University Health Care, Hackensack Meridian Health, St. Joseph's Health and Virtua joined NJHA staff in the Nation's Capital to speak with the members of Congress representing their facilities.

NJHA is a not-for-profit trade association committed to helping its members provide quality, affordable, accessible healthcare to their communities.

SOURCE New Jersey Hospital Association (NJHA)


These press releases may also interest you

at 13:22
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:05
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...



News published on and distributed by: